Work

Eliminating breast surgery for triple negative or HR-/HER2+ breast cancer patients with clinical complete response to combined neoadjuvant chemotherapy and neoadjuvant radiotherapy: A multicenter, phase 2 trial (EBCS).

Year: 2025

Type: article

Study design: Study Protocol

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2025.43.16_suppl.tps630

Authors: Zhengjun Yang, Xin Wang, Xuchen Cao, Aoxiang Chen, Qingsong Pang, Jing Wang, Hong Lu, Ying Zhu, Xiaojing Guo, Fengxia Qin, Xiaolong Qian, Jiangrui Chi, Lin Li, Qian Li

Institutions: Tianjin Medical University Cancer Institute and Hospital, Tianjin Medical University, Zhengzhou University, First Affiliated Hospital of Zhengzhou University

Language: English

Topic: Breast Cancer Treatment Studies

Subfield: Cancer Research

Field: Biochemistry, Genetics and Molecular Biology

Domain: Life Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4410819085

FWCI:

Cites:

Cited by:

Related to: 10